Collectively, these studies provide insights into the anti-tumor activity of AIM2 in colon cancer and CRC, paving the way for further investigation into therapeutic strategies targeting AIM2 in colon cancer and CRC patients (Figure 2). This evidence concerns the gene AIM2 and colonic neoplasm.